Changyu Pan

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

Frank M. Sacks, Michel P. Hermans, Paola Fioretto et al. · Circulation · 2013 · 258 citations · Full text

Medicine, Nephrology, Ophthalmology +12

Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients

Linong Ji, Dayi Hu, Changyu Pan et al. · The American Journal of Medicine · 2013 · 257 citations

Medicine, Internal Medicine, Diabetology +15

An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study

A. Y. T. Wu, Norella Kong, Changyu Pan et al. · Diabetologia · 2004 · 250 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

Bastiaan E. de Galan, Sophia Zoungas, John Chalmers et al. · Diabetologia · 2009 · 240 citations · Full text

Medicine, Internal Medicine, Pharmacology +16